LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 202

Search options

  1. Book: Vaskulitis erkennen, verstehen, behandeln

    Aries, Peer / Hellmich, Bernhard / Iking-Konert, Christof

    mit der seltenen Gefäßentzündung leben: ein Ratgeber für Betroffene

    2023  

    Institution John Grube Foundation
    Author's details herausgegeben von der John Grube Foundarion : Peer Aries, Bernhard Hellmich, Christof Iking-Konert
    Keywords Vaskulitis ; Autoimmunerkrankung ; Rheuma ; Gefäßerkrankung ; Riesenzellarteriitis ; Arteriitis temporalis ; Granulomatose ; Kawasaki-Syndrom ; Morbus Wegener ; Takayasu-Arteriitis ; Innere Medizin ; Dermatologie ; Angioloie ; Entzündungen der Blutgefäße ; 600
    Subject Gefäßentzündung ; Vasculitis ; Vascularitis ; Vaskulitiden ; Angiitis ; Systemische Vasculitis ; Vasculitides ; Angiitides
    Language German
    Size 208 Seiten, Illustrationen, 24 cm x 17 cm
    Edition 1. Auflage
    Publisher TRIAS
    Publishing place Stuttgart
    Publishing country Germany
    Document type Book
    HBZ-ID HT021721705
    ISBN 978-3-432-11555-9 ; 3-432-11555-5 ; 9783432115566 ; 3432115563
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book: Fallbuch Innere Medizin

    Hellmich, Bernhard

    (Fallbuch)

    2020  

    Title variant Innere Medizin
    Author's details Bernhard Hellmich
    Series title Fallbuch
    Keywords Innere Krankheit ; Fallstudie
    Subject Einzelfallanalyse ; Einzelfalldiagnose ; Einzelfallstudie ; Case study ; Fallanalyse ; Innere Erkrankung
    Language German
    Size 460 Seiten, Illustrationen, 24 cm x 17 cm
    Edition 6., vollständig überarbeitete und erweiterte Auflage
    Publisher Georg Thieme Verlag
    Publishing place Stuttgart
    Publishing country Germany
    Document type Book
    Note Zugang zur Online-Ausgabe über Code. Auf dem Umschlag: mit 155 Fällen.
    Old title Vorangegangen ist
    HBZ-ID HT020430817
    ISBN 978-3-13-243202-4 ; 3-13-243202-4 ; 9783132432031 ; 9783132432048 ; 3132432032 ; 3132432040
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Book: Fallbuch Innere Medizin

    Hellmich, Bernhard

    2017  

    Title variant Innere Medizin
    Author's details Bernhard Hellmich
    Keywords Innere Krankheit ; Fallstudie
    Subject Einzelfallanalyse ; Einzelfalldiagnose ; Einzelfallstudie ; Case study ; Fallanalyse ; Innere Erkrankung
    Language German
    Size 444 Seiten, Illustrationen, Diagramme
    Edition 5., vollständig überarbeitete Auflage
    Publisher Georg Thieme Verlag
    Publishing place Stuttgart ; New York
    Publishing country Germany
    Document type Book
    Note Auf dem Umschlag: mit 150 Fällen ; Auf dem Umschlag: Online-Version in der eRef
    Accompanying material Zugang zu Online-Ausgabe über Code
    HBZ-ID HT019299134
    ISBN 978-3-13-240634-6 ; 3-13-240634-1 ; 9783132406353 ; 9783132417700 ; 9783132406360 ; 313240635X ; 313241770X ; 3132406368
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  4. Article ; Online: Epidemiology of ANCA-associated vasculitis: does ancestry play a role?

    Hellmich, Bernhard

    Rheumatology (Oxford, England)

    2023  

    Language English
    Publishing date 2023-12-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/kead652
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book: Mündliche Prüfung Innere Medizin

    Hellmich, Silke / Hellmich, Bernhard

    2017  

    Author's details Silke Hellmich, Bernhard Hellmich
    Keywords Innere Krankheit ; Mündliche Prüfung ; Medizinische Staatsprüfung ; Abschnitt 2
    Subject Ärztliche Staatsprüfung ; Medizinisches Staatsexamen ; Ärztliche Prüfung ; Innere Erkrankung ; Zweiter Abschnitt
    Language German
    Size 286 Seiten, Illustrationen, Diagramme
    Edition 2., vollständig überarbeitete Auflage
    Publisher Georg Thieme Verlag
    Publishing place Stuttgart ; New York
    Publishing country Germany
    Document type Book
    Note 1500 Fragen, Zugang zu Online-Ausgabe über Code und QR-Code
    HBZ-ID HT019404898
    ISBN 978-3-13-240637-7 ; 9783132406384 ; 3-13-240637-6 ; 3132406384
    DOI 10.1055/b-004-140668
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  6. Article ; Online: Response to: Correspondence on 'EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update' by Hellmich

    Hellmich, Bernhard / Jayne, David

    Annals of the rheumatic diseases

    2024  

    Language English
    Publishing date 2024-04-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/ard-2024-225606
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Book: Fallbuch Innere Medizin

    Hellmich, Bernhard

    150 Fälle aktiv bearbeiten

    2012  

    Author's details Bernhard Hellmich
    Keywords Innere Krankheit ; Fallstudie
    Subject Einzelfallanalyse ; Einzelfalldiagnose ; Einzelfallstudie ; Case study ; Fallanalyse ; Innere Erkrankung
    Language German
    Size 440 S. : Ill., graph. Darst.
    Edition 4., überarb. Aufl.
    Publisher Thieme u.a.
    Publishing place Stuttgart u.a.
    Publishing country Germany
    Document type Book
    HBZ-ID HT017385662
    ISBN 978-3-13-132224-1 ; 3-13-132224-1 ; 9783131512949 ; 3131512946
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  8. Article ; Online: Management der ANCA-assoziierten Vaskulitiden.

    Löffler, Christian / Hellmich, Bernhard

    Innere Medizin (Heidelberg, Germany)

    2024  Volume 65, Issue 2, Page(s) 93–106

    Abstract: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an autoimmune-mediated inflammation of small and medium-sized vessels that can affect virtually any organ system and bears the risk of irreversible organ damage. Without treatment ...

    Title translation Management of ANCA-associated vasculitides.
    Abstract Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an autoimmune-mediated inflammation of small and medium-sized vessels that can affect virtually any organ system and bears the risk of irreversible organ damage. Without treatment the mortality rates are high, which necessitates rapid diagnosis and initiation of treatment. Histological confirmation, which is not feasible in all cases, should be strived for, especially to delineate differential diagnoses and vasculitis mimics. The new American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) classification criteria are primarily designed for study purposes and show limitations in the routine application. Globally, the recently updated EULAR recommendations represent the most up to date management guidelines. Therapeutically, rituximab and cyclophosphamide in combination with glucocorticoids remain the pillars of treatment in remission induction for severe organ-threatening and life-threatening diseases. For the first time, mepolizumab and avacopan represent approved treatment options for specific entities that make a significant contribution to steroid reduction. New attention has been paid to patient-reported outcomes, for which a disease-specific outcome questionnaire is now available.
    MeSH term(s) Humans ; Immunosuppressive Agents/therapeutic use ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis ; Rituximab/therapeutic use ; Cyclophosphamide/therapeutic use ; Antibodies, Antineutrophil Cytoplasmic
    Chemical Substances Immunosuppressive Agents ; Rituximab (4F4X42SYQ6) ; Cyclophosphamide (8N3DW7272P) ; Antibodies, Antineutrophil Cytoplasmic
    Language German
    Publishing date 2024-01-22
    Publishing country Germany
    Document type English Abstract ; Journal Article ; Review
    ISSN 2731-7099
    ISSN (online) 2731-7099
    DOI 10.1007/s00108-023-01655-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Glukokortikoide in der Therapie der Riesenzellarteriitis : Wie viel und wie lange und womit einsparen?

    Hellmich, Bernhard

    Zeitschrift fur Rheumatologie

    2021  Volume 80, Issue 4, Page(s) 322–331

    Abstract: Treatment of giant cell arteritis (GCA) with high-dose glucocorticoids (GC) regularly leads to a control of the inflammatory activity, so that high-dose GC is still the recommended standard treatment in the current guidelines; however, after ... ...

    Title translation Glucocorticoids in the treatment of giant cell arteritis : How much, how long and how to spare?
    Abstract Treatment of giant cell arteritis (GCA) with high-dose glucocorticoids (GC) regularly leads to a control of the inflammatory activity, so that high-dose GC is still the recommended standard treatment in the current guidelines; however, after discontinuation of GC treatment or reduction of the GC dosage, relapses occur in up to 70% of patients in the further course of the disease, making it necessary to resume treatment or increase the dosage. As a consequence many patients therefore have to be treated with GC often in high doses over several years, which results in a high cumulative exposure to GC. The risk for GC-associated diseases, such as diabetes, glaucoma, osteoporosis or severe infections is therefore significantly increased for patients with giant cell arteritis. For patients with GC-associated comorbidities or increased risk of developing them or patients with a relapse, the current guidelines therefore recommend GC-sparing treatment with tocilizumab or alternatively methotrexate. It is currently unclear over what period of time patients should be treated with GC and GC-sparing treatment, since high-quality study data on de-escalation strategies for GCA are currently still lacking. Decisions on treatment duration and intensity must therefore be made individually for each patient, taking into account general and patient-specific risk factors for a GC-dependent course, GCA-associated vascular damage (stenoses, aneurysms, visual loss) and treatment-associated complications.
    MeSH term(s) Giant Cell Arteritis/diagnosis ; Giant Cell Arteritis/drug therapy ; Glucocorticoids/adverse effects ; Humans ; Methotrexate ; Osteoporosis ; Recurrence
    Chemical Substances Glucocorticoids ; Methotrexate (YL5FZ2Y5U1)
    Language German
    Publishing date 2021-03-12
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 124985-x
    ISSN 1435-1250 ; 0340-1855 ; 0301-6382
    ISSN (online) 1435-1250
    ISSN 0340-1855 ; 0301-6382
    DOI 10.1007/s00393-021-00975-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Book: Mündliche Prüfung innere Medizin

    Hellmich, Silke / Hellmich, Bernhard

    2011  

    Title variant Innere Medizin
    Author's details Silke Hellmich ; Bernhard Hellmich
    Keywords Innere Krankheit ; Mündliche Prüfung ; Medizinische Staatsprüfung ; Abschnitt 2
    Subject Zweiter Abschnitt ; Ärztliche Staatsprüfung ; Medizinisches Staatsexamen ; Ärztliche Prüfung ; Innere Erkrankung
    Language German
    Size X, 283 S. : Ill., graph. Darst.
    Publisher Thieme
    Publishing place Stuttgart u.a.
    Publishing country Germany
    Document type Book
    Accompanying material 1 DVD (12 cm)
    HBZ-ID HT016807224
    ISBN 978-3-13-144791-3 ; 3-13-144791-5
    Database Catalogue ZB MED Medicine, Health

    Kategorien

To top